SynthesisFrontiers in immunology2024

The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.

Bibhu Prasad Satapathy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.